Topics

Companies Related to "Online therapy helped cardiovascular disease patients with depression" [Most Relevant Company Matches] RSS

11:31 EST 28th January 2020 | BioPortfolio

Here are the most relevant search results for "Online therapy helped cardiovascular disease patients with depression" found in our extensive corporate database of over 50,000 company records.

Showing "Online therapy helped cardiovascular disease patients with depression" Companies 1–25 of 8,700+

Relevant

Vasomedical

Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease. The company’s core technology, EECP® therapy, provides healthcare professionals a non-invasive therapy for patients suffering from cardiovascular diseases. EECP therapy helps patients and their families lead active and productive lives. With ov...


miRagen Therapeutics, Inc.

Cardiovascular disease is the leading cause of death globally. Astonishingly, in the United States, every 37 seconds a person dies from cardiovascular disease. For survivors, life changes dramatically after an adverse heart event. Because of the significant toll that cardiovascular and muscle disease takes on patients, miRagen Therapeutics, Inc., was found...

EPIX Pharmaceuticals

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products through the use of proprietary technology to better diagnose, treat and manage patients. The company has five internally-discovered therapeutic and imaging drug candidates currently in clinical trials targeting conditions such as depression, Alzheimer's disease, ...


Corautus Genetics

Corautus Genetics is dedicated to the clinical development of new therapies for the treatment of patients with serious diseases, including severe cardiovascular and peripheral vascular disease. Our goal is to become a world leader in introducing genetic therapy products into medical practice. In the Fall of 2004, Corautus initiated the largest trial of its kind in the United States for angina pati...

Reprieve Cardiovascular

Reprieve Cardiovascular’s Guided Diuretic Therapy is designed to manage fluids during diuretic therapy for patients with Acute Decompensated Heart Failure (ADHF), and may relieve a number of symptoms related to this condition. The therapy has the potential to enable precise and predictable management of a patient’s fluid levels, guarding against ...

MyoKardia, Inc.

MyoKardia is dedicated to revolutionizing the treatment of genetic cardiovascular disease. The company’s proprietary platform combines recent breakthroughs in muscle biology with leading-edge cardiovascular disease genetics. This personalized, genetically targeted approach focuses on the underlying cause of disease and has the potential to drastically...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 38 physicians and 15 mid-level providers in 17 locations, and is one of the largest cardiovasc...

Reprieve Cardiovascular, Inc.

Reprieve Cardiovascular’s Guided Diuretic Therapy is designed to manage fluids during diuretic therapy for patients with Acute Decompensated Heart Failure (ADHF), and may relieve a number of symptoms related to this condition. The therapy has the potential to enable precise and predictable management of a patient’s fluid levels, guarding against ...

Greenbrook TMS Inc.

Operating through 47 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 36 physicians and 14 mid-level providers in 15 locations, and is one of the largest cardiovascu...

Esperion

We discover and develop pharmaceutical products for the treatment of cardiovascular disease, which is disease of the heart and the body's blood vessels and related organs. We intend to commercialize a novel class of drugs that focus on a new treatment approach we call "HDL Therapy," which is based on our understanding of high density lipoprotein, or HDL, function. HDL is the primary facilitator of...

Nuvelo

Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes several acute cardiovascular and oncology programs. The cardiovascular portfolio includes three programs: alfimeprase, a direct acting thr...

CardioVascular BioTherapeutics

CardioVascular BioTherapeutics, Inc. (OTC/BB: CVBT) is a biopharmaceutical company focused on developing protein drug candidates to be used in the treatment of cardiovascular disease, the worldwide leading cause of death. The Company is developing injectable and topical formulations of its active pharmacological ingredient (API) to facilitate the growth of new blood vessels (angiogenesis) in the h...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

Tyler Cardiovascular Consultants

To provide high-quality preventive, diagnostic and therapeutic cardiovascular services in order to promote cardiovascular health for our patients.To be the premiere group providing quality cardiovascular services and research in East Texas.Our Values • Excellent Quality & Service...for our patients and referring physicians • Honesty, Integrity & Compassion...in our activities with our employee...

Curidium Medica plc

Bringing the right medicine to the right patientThrough understanding the biological, genetic and environmental causes of disease, Curidium believes future drug development will be targeted to more accurately defined subgroups of patients who will benefit from focused drug therapies. This approach has been successfully applied in the areas of cardiovascular and cancer therapeutics. Herceptin®, wh...

Cyberonics, Inc.

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the...

The LIfe Score Clinic

The LifeScore Clinic was founded in 1999 by Dr. C. Michael Wright. Since then, the clinic has seen over 15,000 patients. Dr. Wright sees patients to review the results of their diagnostic studies, and also has a busy cardiology practice. He specializes in providing comprehensive programs for disease prevention. Dr. Tabita Wright joined the center in 2000 as it expanded its scanning beyond the hear...

Aterovax SA

Aterovax is developing innovative products for the cardiovascular disease market based on a unique understanding of atherosclerosis, the condition responsible for most cardiovascular problems. Aterovax’s first product is a diagnostic blood test to measure activity of secretory phospholipase A2 (sPLA2), a powerful biomarker that provides physicians wit...

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patie...

Boston Heart Diagnostics

Boston Heart Diagnostics is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and integrated customized lifestyle programs that have the power to change the way clinicians and patients communicate about disease and improve heart health. Boston Heart looks beyond th...

Cardiovascular Institute of the South (CIS)

CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine. With a team of nearly 450 dedicated team members, CIS serves communities throughout Louisiana, as well as national and international patients, at its 10 clinics. CIS consistently positions itself at the forefront of technology by providing the most up-to-date technolog...

Pivotal Therapeutics Inc.

With offices in Toronto, Canada and Boca Raton, Florida, Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF; CNSX: PVO) specialty pharmaceutical company with a focus on cardiovascular and overall health. Pivotal Therapeutics' lead product VASCAZENTM is a prescription only medical food formulated to meet the dietary Omega-3 deficient needs of patients ...

Physical Therapy Pal

Physical Therapy Pal (PT PAL) is the first clinical HIPAA-compliant mobile application used between physical therapists and patients. PT PAL helps improve outcomes by engaging patients in their therapy. PT PAL gives visibility into patient regimen adherence and the ability to monitor and modify therapy prescriptions remotely. PT PAL is an aid ...

Corvidia Therapeutics Inc.

Corvidia Therapeutics Inc. is a clinical stage biotechnology company based in Waltham, Massachusetts pioneering the next generation of cardiovascular and cardio-renal therapies. Corvidia’s pipeline programs utilize functional genomics to precisely identify patients with unique sensitivity to specific biologic pathways, allowing for rapid developmen...


More From BioPortfolio on "Online therapy helped cardiovascular disease patients with depression"

Quick Search

Corporate Database Quicklinks